Kindred Biosciences Inc (NASDAQ:KIN)

9.13
Delayed Data
As of Jul 23
 -0.04 / -0.44%
Today’s Change
3.20
Today|||52-Week Range
9.28
+111.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.002.0M
 
 
Cost of Goods Sold0.000.000.00324.0K
 
 
Depreciation And Amortization146.0K155.0K475.0K805.0K
 
 
 
 
 
 
Operating ExpensesGross Income-146.0K-155.0K-475.0K837.0K
 
 
 
 
 
General Expenses27.1M22.0M31.2M52.1M
 
 
 
 
 
Research And Development19.4M13.9M17.7M26.4M
 
 
 
 
 
Total Operating Expenses27.3M22.2M31.7M53.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.3M-22.2M-31.7M-51.3M
 
 
 
 
 
Extraordinary Charge0.00-655.0K0.000.00
 
 
Other Expenses132.0K325.0K774.0K1.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.1M-22.5M-30.9M-49.7M
 
 
 
 
 
Net Income-27.1M-22.5M-30.9M-49.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.8M19.9M25.1M31.0M
 
 
 
 
 
Shares To Calculate EPS Diluted19.8M19.9M25.1M31.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.37-$1.13-$1.23-$1.60
 
 
 
 
 
EPS Diluted-$1.37-$1.13-$1.23-$1.60